Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 16/20 | 0.45 |
| ▸ | APLNR | P35414 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.42 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30839888 | 0.93 | APLNR (0.46) | GLP1RAPLNRKEAP1C5AR1 | |
| SCHEMBL30293824 | 0.91 | GLP1R (0.40) | GLP1RKEAP1VIPR1 | |
| SCHEMBL30369010 | 0.88 | GLP1R (0.45) | GLP1RVIPR1 | |
| SCHEMBL29649781 | 0.88 | AGTR2 (0.51) | GLP1RVIPR1C5AR1 | |
| SCHEMBL30811634 | 0.87 | GLP1R (0.45) | GLP1RKEAP1VIPR1C5AR1 | |
| SCHEMBL31060878 | 0.86 | ENPEP (0.47) | — | |
| SCHEMBL29701259 | 0.85 | GLP1R (0.49) | GLP1RVIPR1 | |
| SCHEMBL30823264 | 0.85 | APLNR (0.50) | GLP1RAPLNRKEAP1C5AR1 | |
| SCHEMBL31414089 | 0.85 | APLNR (0.44) | GLP1RAPLNRC5AR1 | |
| SCHEMBL30455424 | 0.85 | GLP1R (0.50) | GLP1RKEAP1VIPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082716-A1 | REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-03-13 | — | — | US | claimed |
| US-20250082716-A1 | REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-03-13 | — | — | US | disclosed |
| WO-2024054198-A1 | REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-03-14 | — | — | WO | disclosed |